In Complicated UTI, Cefiderocol Noninferior to Imipenem-Cilastin

Share this content:
In Complicated UTI, Cefiderocol Noninferior to Imipenem-Cilastin
In Complicated UTI, Cefiderocol Noninferior to Imipenem-Cilastin

MONDAY, Oct. 29, 2018 (HealthDay News) -- For complicated urinary tract infections caused by multidrug-resistant Gram-negative uropathogens, the siderophore cephalosporin cefiderocol is non-inferior to imipenem-cilastatin, according to a study published online Oct. 25 in The Lancet Infectious Diseases.

Simon Portsmouth, M.D., from Shionogi Inc., in Florham Park, New Jersey, and colleagues conducted a phase 2 non-inferiority trial at 67 hospitals in 15 countries. A total of 452 patients admitted to the hospital with a clinical diagnosis of complicated urinary tract infection with or without pyelonephritis or with acute uncomplicated pyelonephritis were randomized to intravenous infusions of cefiderocol or imipenem-cilastatin every eight hours for seven to 14 days; 300 and 148 patients, respectively, received treatment. A total of 252 patients in the cefiderocol group and 119 patients in the imipenem-cilastatin group had a qualifying Gram-negative uropathogen and were included in the analysis of the primary end point of a composite of clinical and microbiological outcomes seven days after cessation of treatment.

The researchers found that 73 and 55 percent of patients in the cefiderocol and imipenem-cilastatin groups, respectively, achieved the primary efficacy end point, with an adjusted treatment difference of 18.58 percent, establishing the noninferiority of cefiderocol. The patients tolerated cefiderocol well; adverse events occurred in 41 and 51 percent of patients in the cefiderocol and imipenem-cilastatin groups, respectively.

"As a siderophore antibiotic, cefiderocol is a novel approach that might be used to overcome Gram-negative resistance," the authors write.

The authors disclosed ties to Shionogi & Co. Ltd. and Shionogi Inc., which funded the study.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Wait Times Have Improved in VA Health Care System

Wait Times Have Improved in VA Health Care ...

Wait times similar to private sector in 2014 but shorter overall and in some specialties in 2017

Medication Treatment for Substance Abuse Up in Facilities

Medication Treatment for Substance Abuse Up in Facilities

2007 to 2016 saw increase in use of medication treatment, reaching 36.1 percent in 2016

Mindfulness, Stress Linked to Menopausal Symptoms

Mindfulness, Stress Linked to Menopausal Symptoms

Link between mindfulness and symptoms more robust in women experiencing higher stress

is free, fast, and customized just for you!




Already a member?

Sign In Now »